FDA warning letter
Closeout letter
Issue date
12 Jul 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
27 Aug 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Issue date
18 Jan 2023
Headquarters
Sites
Issue date
Issuing office
Posted date
Subject
Products & Services
Issue date